Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r

Antela López, Antonio

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/5888

PMID: 24908550

DOI: 10.1016/S1473-3099(14)70796-0

ISSN: 1473-3099

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2014

Journal title

LANCET INFECTIOUS DISEASES

Type of content

Artigo